All In MedTech

FDA Clearance Tracker · P150038-S009

Exablate Model 4000 System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 28, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 28, 2019

Approved

Time to decision

193 days

Received Dec 17, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150038-S009
Device name
Exablate Model 4000 System
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Dec 17, 2018
Decided
Jun 28, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

Approval for the Exablate 4000 Type 1.1 System SW Version 7.3 to support the operation of the Type 1.1 System SW version 7.2 and to include compatibility with the GE Premier Magnetic Resonance (MR) System.

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.